Purchase Order 75N93021P01365
Award Date
9/13/21
Potential Completion Date
10/25/21
Potential Value
$340K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,275 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for one NEXTSEQ 2000 SEQUENCING SYSTEM to support ongoing COVID-19 and infectious disease research. Delivery is required by January 31, 2023 in Bethesda, Maryland per the original solicitation seeking offers for the Illumina NextSeq-2000 sequencing system and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, to provide a NEXTSEQ 2000 SEQUENCING SYSTEM in support of COVID-19 research. The $338,350.00 contract has a completion date of September 25, 2020 and was awarded on June 22, 2020 with no set-aside designation. Illumina has previously provided sequencing...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
This $340,025 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Illumina, Inc. to deliver an Illumina NextSeq 2000 Sequencer or equivalent high-throughput next-generation sequencing system. The solicitation sought quotes for this sequencing equipment to increase NIAID's capacity for sequencing samples related to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 sequencing system to support COVID-19 research. The $341,700.00 award did not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents that has received prior federal contract awards from agencies such as the National Institutes of Health,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $341,700.00 firm fixed price purchase order to Illumina, Inc. for the NEXTSEQ 2000 SEQUENCING SYSTEM in support of COVID-19 response efforts. The award was made on August 17, 2020 with a completion date of December 31, 2020. Illumina is a manufacturer and provider of sequencing and array-based genomic analysis solutions, and has a history of providing...
Illumina, Inc. was awarded a $898,275 firm fixed-price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide an Illumina NovaSeq 6000 sequencing system. The contract is in support of the Department of Health and Human Services' efforts responding to the Coronavirus Disease 2019 pandemic and will run from September 2021 through September 2022. Performance will take place in San Diego, California. No set-aside designation or...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the NextSeq 1000 Sequencing System. The $213,150.00 contract supports NIAID's Vaccine Immunology Program's research into monoclonal antibodies and vaccines for infectious diseases such as HIV, influenza, Ebola, and SARS-CoV-2....
The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $213,150 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 1000 Sequencing System. The award was made under simplified acquisition procedures solicitation number RFQ-NIH-NIAID-2183146, which sought quotes for the sequencing system as well as its delivery to NIH in Bethesda, Maryland, installation, setup, operator training, and maintenance/support services. The...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is for the purchase of NextSeq 1000/2000 and MiSeq reagent kits, valued at $109,656.60. The order supports the agency's Coronavirus COVID-19 response efforts. The contract is awarded on a firm fixed-price basis with no set-aside...